Amir S, Laique F, Azam MM. Unlocking hope: talquetamab in multiple myeloma treatment: a bispecific breakthrough targeting CD3 and GPRC5D. Int J Sci Rep [Internet]. 2024 May 23 [cited 2025 Sep. 26];10(6):221-4. Available from: https://www.sci-rep.com/index.php/scirep/article/view/1334